Research Progress of Aptamer-mediated Tumor Immunotherapy

Zhou Ling-Li,Ye Mao

DOI: https://doi.org/10.16476/j.pibb.2021.0195

2022-01-01

PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS

Abstract:Tumor immunotherapy is a novel strategy for cancers,which has great significance and applicationprospects in clinical treatment.It mainly includes adoptive cell therapy,tumor vaccines and monoclonal antibodytherapy.Antibodies are widely used in tumor immunotherapy,but their price is too high,the quality is easilyinfluenced by different batches and have immunogenicity.Aptamers,also known as"chemical antibodies",areshort single-stranded oligonucleotides which bind to their targets with high specificity and affinity.Aptamerswhich have low immunogenicity,are synthesized at low cost and quality stability.Based on these advantages,aptamers have been developed for tumor immunotherapy in recent years which mainly includes two aspects.Oneis to select immune-related aptamers,and the other is to expand the application of aptamers that have beenreported to tumor immunotherapy.Using immune checkpoints,co-stimulatory receptors or cytokines as targets,the aptamers can be obtained through screening.However,it is uncertain whether the aptamer has the biologicalfunction of regulating the anti-tumor immune response.Therefore,the process of screening should be improvedby adding appropriate screening pressure to obtain functional aptamers that can regulate antitumor immuneresponse.There are many aptamers which have been reported,but rarely have been investigated for furtherresearch and application.So we can further develop these aptamers for tumor immunotherapy.For example,aptamers can be coupled with siRNA or nanomaterials to indirectly regulate tumor immune processes.Themodification of membrane of immune cells with aptamers confers the immune cells targeted tumor-killing effects.Aptamers play an important role in tumor immunotherapy in a variety of ways,and have great potential to bedeveloped for clinical treatment.We need to improve the aptamer screening process to obtain aptamers that havepowerful biological functions quickly and maximize the use of the aptamers that have been obtained